Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The Health and Social Effects of Nonmedical Cannabis Use.World Health Organization, Geneva, Switzerland2016
- Drug Facts: National Trends.National Institute on Drug Abuse, Bethesda, Md2014
- Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health.Substance Abuse and Mental Health Services Administration, Rockville, Md2019
Daniller A. Two-thirds of Americans support marijuana legalization. Pew Research Center; 2019. Available at: https://www.pewresearch.org/fact-tank/2019/11/14/americans-support-marijuana-legalization/. Accessed November 13, 2020.
- Marijuana legalization and youth.Pediatrics. 2020; 145: S165-S174
- Risks and benefits of marijuana use: a national survey of U.S. adults.Ann Intern Med. 2018; 169: 282-290
- Adverse health effects of marijuana use.N Engl J Med. 2014; 370: 2219-2227
- Rising trends in hospitalizations for cardiovascular events among young cannabis users (18-39 years) without other substance abuse.Medicina (Kaunas). 2019; 55: 438
- Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States.Cureus. 2017; 9: e1816
- Primary causes of hospitalizations and procedures, predictors of in-hospital mortality, and trends in cardiovascular and cerebrovascular events among recreational marijuana users: a five-year nationwide inpatient assessment in the United States.Cureus. 2018; 10: e3195
- Marijuana use among young adults (18-44 years of age) and risk of stroke: a behavioral risk factor surveillance system survey analysis.Stroke. 2020; 51: 308-310
Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Available at: https://www.cdc.gov/brfss/index.html. Accessed November 13, 2020.
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System (BRFSS). Module data for analysis: 2016 BRFSS. Available at: https://www.cdc.gov/brfss/annual_data/2016/pdf/2016moduleanalysis.pdf. Accessed November 13, 2020.
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System (BRFSS). Complex sampling weights and preparing 2017 BRFSS module data for analysis. Available at:https://www.cdc.gov/brfss/annual_data/2017/pdf/Complex-Smple-Weights-Prep-Module-Data-Analysis-2017-508.pdf. Accessed November 13, 2020.
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System (BRFSS). Complex sampling weights and preparing 2018 BRFSS module data for analysis. Available at:https://www.cdc.gov/brfss/annual_data/2018/pdf/Complex-Smple-Weights-Prep-Module-Data-Analysis-2018-508.pdf. Accessed November 13, 2020.
- Role of cannabis in cardiovascular disorders.J Thorac Dis. 2017; 9: 2079-2092
- Stroke in young cannabis users (18-49 years): National trends in hospitalizations and outcomes.Int J Stroke. 2020; 15: 535-539
- Cannabis use and acute coronary syndrome.Clin Toxicol (Phila). 2019; 57: 831-841
- Cocaine and marijuana use among young adults with myocardial infarction.J Am Coll Cardiol. 2018; 71: 2540-2551
- Marijuana use and coronary artery disease in young adults.PLoS One. 2020; 15e0228326
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.Nat Rev Cardiol. 2018; 15: 151-166
- The endocannabinoid system as an emerging target of pharmacotherapy.Pharmacol Rev. 2006; 58: 389-462
- The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications.Br J Pharmacol. 2011; 163: 1423-1431
- Targeting the endocannabinoid system: to enhance or reduce?.Nat Rev Drug Discov. 2008; 7: 438-455
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Br J Pharmacol. 2010; 160: 688-700
Kattoor A, Mehta JL; American College of Cardiology. Marijuana and coronary heart disease. Available at: https://www.acc.org/latest-in-cardiology/articles/2016/09/22/08/58/marijuana-and-coronary-heart-disease. Accessed November 13, 2020.
- Cardiovascular complications of marijuana and related substances: a review.Cardiol Ther. 2018; 7: 45-59
- The association of cannabis use and cardiac dysrhythmias: a systematic review.Clin Toxicol (Phila). 2020; 58: 861-869
- Cannabis use and later life outcomes.Addiction. 2008; 103 (discussion 977-968): 969-976
- Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence.Subst Abus. 2013; 34: 298-305
- Getting higher: co-occurring drug use among marijuana-using emerging adults.J Addict Dis. 2014; 33: 202-209
- Marijuana use in patients with cardiovascular disease: JACC review topic of the week.J Am Coll Cardiol. 2020; 75: 320-332
- Pulmonary hazards of smoking marijuana as compared with tobacco.N Engl J Med. 1988; 318: 347-351
- A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011.BMC Med Res Methodol. 2013; 13: 49
- A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007-2008.Prev Med. 2012; 54: 381-387
Conflict of Interest: None.
Authorship: All authors had access to the data and participated actively in writing the manuscript.